Edgar Ben-Josef
Department of Radiation Oncology
University of Michigan
Ann Arbor
MI 48109
USA
Name/email consistency: high
- Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. Ben-Josef, E., Moughan, J., Ajani, J.A., Flam, M., Gunderson, L., Pollock, J., Myerson, R., Anne, R., Rosenthal, S.A., Willett, C. J. Clin. Oncol. (2010)
- Chemoradiotherapy for unresectable pancreatic cancer. Ben-Josef, E., Lawrence, T.S. Int. J. Clin. Oncol. (2008)
- Radiotherapy for unresectable hepatic malignancies. Ben-Josef, E., Lawrence, T.S. Semin. Radiat. Oncol (2005)
- Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. Ben-Josef, E., Normolle, D., Ensminger, W.D., Walker, S., Tatro, D., Ten Haken, R.K., Knol, J., Dawson, L.A., Pan, C., Lawrence, T.S. J. Clin. Oncol. (2005)
- Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Ben-Josef, E., Shields, A.F., Vaishampayan, U., Vaitkevicius, V., El-Rayes, B.F., McDermott, P., Burmeister, J., Bossenberger, T., Philip, P.A. Int. J. Radiat. Oncol. Biol. Phys. (2004)









